A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be effective as 6 months-therapy...
Date First Received: February 28, 2008
Last Updated: March 10, 2008
Verified by: Hamamatsu University, March 2008
Clinical Trial Phase: Phase 4 | Start Date: June 2007
Overall Status: Recruiting
Estimated Enrollment: 50
Brief Summary
Official Title: “Phase 4, Randomized Study of Three Months-Prednisolone Therapy in the Treatment of Chronic Eosinophilic Pneumonia”
Condition Keyword(s):
A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be effective as 6 months-therapy.
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Outcome Measures for this Clinical Trial
Primary:
- Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia three-year Yes
Secondary:
- Safety of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia three-year Yes
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- biopsy-proven chronic eosinophilic pneumonia
Exclusion Criteria:
- patients who received oral glucocorticosteroid (more than 10mg)
- immunosuppressive drug
Clinical Trials Locations, Contact Details, and Sponsors
Lead Sponsor: Hamamatsu University
Hamamatsu University School of Medicine
Hamamatsu Japan
Overall Clinical Trial Officials and Contacts
Kingo Chida, MD,PhD Study Chair Hamamatsu University
Overall Contact: Naoki Inui, MD,PhD 81-53-435-2385 may15@hama-med.ac.jp
Additional Information
Information obtained from ClinicalTrials.gov on July 23, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00632554
Study ID Number: Hamamatsu-18-67
ClinicalTrials.gov Identifier: NCT00632554
Health Authority: Japan: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
